词条 | Polymyositis |
释义 |
| name = Polymyositis | synonyms = | image = Polymyositis HE.jpg | caption = Micrograph of polymyositis. Muscle biopsy. H&E stain. | pronounce = | field = Rheumatology | symptoms = | complications = | onset = | duration = | types = | causes = | risks = | diagnosis = | differential = | prevention = | treatment = | medication = | prognosis = | frequency = | deaths = }}Polymyositis (PM) is a type of chronic inflammation of the muscles (inflammatory myopathy) related to dermatomyositis and inclusion body myositis. Its name means "inflammation of many muscles" (poly- + myos- + -itis). The inflammation of polymyositis is mainly found in the endomysial layer of skeletal muscle, whereas dermatomyositis is characterized primarily by inflammation of the perimysial layer of skeletal muscles.[1] Signs and symptomsThe hallmark of polymyositis is weakness and/or loss of muscle mass in the proximal musculature, as well as flexion of the neck and torso.[1] These symptoms can be associated with marked pain in these areas as well. The hip extensors are often severely affected, leading to particular difficulty in climbing stairs and rising from a seated position. The skin involvement of dermatomyositis is absent in polymyositis. Dysphagia (difficulty swallowing) or other problems with esophageal motility occur in as many as 1/3 of patients. Low grade fever and enlarged lymph nodes may be present. Foot drop in one or both feet can be a symptom of advanced polymyositis and inclusion body myositis. The systemic involvement of polymyositis includes interstitial lung disease (ILD) and heart disease, such as heart failure and conduction abnormalities.[2] Polymyositis tends to become evident in adulthood, presenting with bilateral proximal muscle weakness often noted in the upper legs due to early fatigue while walking. Sometimes the weakness presents itself as an inability to rise from a seated position without help or an inability to raise one's arms above one's head. The weakness is generally progressive, accompanied by lymphocytic inflammation (mainly cytotoxic T cells). Associated illnessesPolymyositis and the associated inflammatory myopathies have an associated increased risk of cancer.[3] The features they found associated with an increased risk of cancer was older age, age greater than 45, male sex, difficulty swallowing, death of skin cells, cutaneous vasculitis, rapid onset of myositis (<4 weeks), elevated creatine kinase, higher erythrocyte sedimentation rate and higher C-reactive protein levels. Several factors were associated with lower-than-average risk, including the presence of interstitial lung disease, joint inflammation/joint pain, Raynaud's syndrome, or anti-Jo-1 antibody.[3] The malignancies that are associated are nasopharyngeal cancer, lung cancer, non-Hodgkin's lymphoma and bladder cancer, amongst others.[4] Cardiac involvement manifests itself typically as heart failure, and is present in up to 77% of patients.[2] Interstitial lung disease is found in up to 65% of patients with polymyositis, as defined by HRCT or restrictive ventilatory defects compatible with interstitial lung disease.[5] CausesPolymyositis is an inflammatory myopathy mediated by cytotoxic T cells with an as yet unknown autoantigen, while dermatomyositis is a humorally mediated angiopathy resulting in myositis and a typical dermatitis.[6] The cause of polymyositis is unknown and may involve viruses and autoimmune factors. Cancer may trigger polymyositis and dermatomyositis, possibly through an immune reaction against cancer that also attacks a component of muscles.[7] There is tentative evidence of an association with celiac disease.[8] DiagnosisDiagnosis is fourfold: History and physical examination, elevation of creatine kinase, electromyograph (EMG) alteration, and a positive muscle biopsy.[9] The hallmark clinical feature of polymyositis is proximal muscle weakness, with less important findings being muscle pain and dysphagia. Cardiac and pulmonary findings will be present in approximately 25% of cases of patients with polymyositis. Sporadic inclusion body myositis (sIBM): IBM is often confused with (misdiagnosed as) polymyositis or dermatomyositis that does not respond to treatment is likely IBM. sIBM comes on over months to years; polymyositis comes on over weeks to months. Polymyositis tends to respond well to treatment, at least initially; IBM does not. TreatmentThe first line treatment for polymyositis is corticosteroids. Specialized exercise therapy may supplement treatment to enhance quality of life. EpidemiologyPolymyositis, like dermatomyositis, strikes females with greater frequency than males. Notable cases
See also
References1. ^1 {{cite journal | vauthors = Strauss KW, Gonzalez-Buritica H, Khamashta MA, Hughes GR | title = Polymyositis-dermatomyositis: a clinical review | journal = Postgraduate Medical Journal | volume = 65 | issue = 765 | pages = 437–43 | date = July 1989 | pmid = 2690042 | pmc = 2429417 | doi = 10.1136/pgmj.65.765.437}} 2. ^1 {{cite journal | vauthors = Zhang L, Wang GC, Ma L, Zu N | title = Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review | journal = Clinical Cardiology | volume = 35 | issue = 11 | pages = 686–91 | date = November 2012 | pmid = 22847365 | doi = 10.1002/clc.22026 }} 3. ^1 {{cite journal | title=Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis |author1=Xin Lu |author2=Hanbo Yang |author3=Xiaoming Shu |author4=Fang Chen |author5=Yinli Zhang |author6=Sigong Zhang |author7=Qinglin Peng |author8=Xiaolan Tian |author9=Guochun Wang | journal=PLOS ONE | year=2014 | volume=9 | issue=4 | pages=e94128 | doi=10.1371/journal.pone.0094128 | pmid=24713868 | pmc=3979740|bibcode=2014PLoSO...994128L }} 4. ^{{cite journal |last=Hill |first=C.L. |last2=Zhang |first2=Y. |last3=Sigurgeirsson |first3=B. |last4=Pukkala |first4=E. |last5=Mellemkjaer |first5=L. |last6=Airio |first6=A. |last7=Evans |first7=S.R. |last8=Felson |first8=D.T. |title=Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study |journal=Lancet |volume=357 |issue=9250 |pages=96–100 |date=January 2001 |pmid=11197446 |doi=10.1016/S0140-6736(00)03540-6 |url= http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)03540-6/abstract |accessdate=20 April 2015}} 5. ^{{cite journal | vauthors = Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G | title = Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis | journal = Annals of the Rheumatic Diseases | volume = 63 | issue = 3 | pages = 297–301 | date = March 2004 | pmid = 14962966 | pmc = 1754925 | doi = 10.1136/ard.2003.006122}} 6. ^{{cite journal | title=Polymyositis, invasion of non-necrotic muscle fibres, and the art of repetition | author=Gerald J D Hengstman, Baziel G M van Engelen | journal=British Medical Journal | year=2004 | volume=329 | issue=7480 | doi=10.1136/bmj.329.7480.1464 | pages=1464–1467 | pmid=15604185 | pmc=535982}} 7. ^{{cite web |url=http://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/autoimmune-disorders-of-connective-tissue/polymyositis-and-dermatomyositis |title=Polymyositis and Dermatomyositis |first=Rula A. |last=Hajj-ali |work=Merck Manual Home Edition |date=August 2013 |accessdate=20 April 2015 |deadurl=no |archiveurl=https://web.archive.org/web/20150419101643/http://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/autoimmune-disorders-of-connective-tissue/polymyositis-and-dermatomyositis |archivedate=19 April 2015 |df= }} 8. ^{{cite journal| vauthors=Shapiro M, Blanco DA| title=Neurological Complications of Gastrointestinal Disease. | journal=Semin Pediatr Neurol | year= 2017 | volume= 24 | issue= 1 | pages= 43–53 | pmid=28779865 | doi=10.1016/j.spen.2017.02.001 | type=Review }} 9. ^{{cite journal | vauthors = Scola RH, Werneck LC, Prevedello DM, Toderke EL, Iwamoto FM | title = Diagnosis of dermatomyositis and polymyositis: a study of 102 cases | journal = Arquivos de Neuro-Psiquiatria | volume = 58 | issue = 3B | pages = 789–99 | date = September 2000 | pmid = 11018813 | doi = 10.1590/S0004-282X2000000500001}} 10. ^{{cite news|url=https://www.nytimes.com/2007/01/27/obituaries/27christensen.html|title=Dan Christensen, 64, Painter of Abstract Art, Dies|date=27 January 2007|newspaper=The New York Times|accessdate=20 April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20150605102517/http://www.nytimes.com/2007/01/27/obituaries/27christensen.html|archivedate=5 June 2015|df=}} 11. ^{{cite web |url=http://www.sfgate.com/news/article/OBITUARY-Robert-Erickson-2842509.php |title=Obituary - Robert Erickson |date=29 April 1997 |publisher=SF Gate |accessdate=20 April 2015 |deadurl=no |archiveurl=https://web.archive.org/web/20150101194821/http://www.sfgate.com/news/article/OBITUARY-Robert-Erickson-2842509.php |archivedate=1 January 2015 |df= }} 12. ^{{cite book|first=George |last=Stevens, Jr. |title=Conversations with the Great Moviemakers of Hollywood's Golden Age at the American Film Institute |year=2006|publisher=Knopf |isbn=978-1-4000-4054-4 |page=427}} 13. ^{{cite book |first=Kevin |last=Brownlow |title=David Lean: A Biography |url=https://books.google.com/books?id=u4AdbfjHZf0C&pg=PT1466 |date=1996 |publisher=Macmillan |isbn=978-1-4668-3237-4 |pages=1466–1467 |accessdate=20 April 2015 |deadurl=no |archiveurl=https://web.archive.org/web/20180113024122/https://books.google.com/books?id=u4AdbfjHZf0C&pg=PT1466 |archivedate=13 January 2018 |df= }} External links{{Medical resources| DiseasesDB = 10343 | ICD10 = {{ICD10|M|33|2|m|30}} | ICD9 = {{ICD9|710.4}} | ICDO = | OMIM = | MedlinePlus = 000428 | eMedicineSubj = med | eMedicineTopic = 3441 | eMedicine_mult = {{eMedicine2|emerg|474}} | MeshID = D017285 | Scholia = Q980926 }}{{Systemic connective tissue disorders}} 3 : Inflammations|Steroid-responsive inflammatory conditions|Systemic connective tissue disorders |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。